News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

During the June 14th RECOVER Research Review (R3) Seminar, researchers presented on the clinical spectrum of PASC with a focus on neurocognitive function. Presenters discussed the current understanding of neurocognitive function in PASC patients, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.
NIH Director Lawrence Tabak, DDS, PhD, describes how artificial intelligence (AI) can help us learn why some people are more likely to have Long COVID.
During the May 24th RECOVER Research Review (R3) Seminar, researchers presented on using electronic health records and real-world data to understand PASC. Presenters discussed how this data can be used to improve diagnosis and treatment of PASC.
During the May 10th RECOVER Research Review (R3) Seminar, researchers presented dysautonomia and its connection to PASC, including diagnosis, treatment and recent research findings. Presenters discussed what is known about dysautonomia and POTS (Postural Orthostatic Tachycardia Syndrome), treatment strategies, and how PASC can cause dysautonomia.
During the April 26th RECOVER Research Review (R3) Seminar, researchers presented on COVID-19 in children, including MIS-C (multi-inflammatory syndrome in children). Presenters discussed what is known about this topic, the gaps in our knowledge, and how RECOVER will contribute to filling these gaps.
During the April 12th RECOVER Research Review (R3) Seminar, researchers presented on commonalities between ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) and PASC. Presenters discussed what is known about these disorders, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.
This publication describes the study plan RECOVER researchers follow when answering questions about how Long COVID affects people aged 18 years and older.